2020
Suh M , Movva N , Fryzek J, Bylsma L , Demont C, Rizzo C, Nelson CB. Systematic literature review of respiratory syncytial virus (RSV) burden and RSV clinical sequelae among infants and children up to 5 years of age living in the United States. IDWeek Virtual Conference on Infectious Disease, October 2020.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Epidemiology , Systematic Review
Fergie J, Gonzales T, Suh M , Jiang X , Fryzek J, Howard A, Bloomfield A. Medically attended respiratory syncytial virus hospitalizations (RSVH) and all-cause bronchiolitis hospitalizations (BH) among children aged ≤24 months at RSV season start with higher-risk congenital heart disease (CHD) before and after the 2014 American Academy of Pediatrics (AAP) policy. Presentation to IDWeek Conference on Infectious Disease, Virtual, October 2020.
Publication: Abstracts and Presentations
/ Topics: Epidemiology , Rare Diseases
Li S, Peng Y, Liu J, Li S, Raskin L, Kelsh MA , et al. 2020. Variations in hospitalization and emergency department/observation stays using the oncology care model methodology in Medicare data. Curr Med Res Opin 36(9):1519–1527; doi: 10.1080/03007995.2020.1801403 . PMID: 32715807.
View Abstract
Publication: Manuscripts
/ Topics: Cancer
Gawade PL, Li S, Henry D, Smith N, Belani R, Kelsh MA , et al. 2020. Patterns of granulocyte colony-stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy. Support Care Cancer 28(9):4413–4424; doi: 10.1007/s00520-020-05295-2 . PMID: 31919669.
View Abstract
Publication: Manuscripts
/ Topics: Cancer
Locatelli F, Whitlock JA, Peters C, Chen-Santel C, Chia V, Dennis RM, … Kelsh MA , et al. 2020. Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia. Leukemia 34(9):2473–2478; doi: 10.1038/s41375-020-0770-8 . PMID: 32094465.
View Abstract
Publication: Manuscripts
/ Topics: Cancer , Epidemiology
Fryzek J, Bylsma L , Mease K, Movva N , Welsh BT, Wood M. 2020. Critical insights into nonclinical toxicology and real-world evidence essential for a successful rare disease product launch. EpidStrategies, Inc. White Paper .
View Abstract
Publication: White paper
/ Topics: nonclinical safety assessment
Frankenfeld CL . Dietary data processing and analysis: Considerations for microbiome-diet research. Best Practices for Characterization of Diet in Gut Microbiome Research: Focus on Dietary Assessment, Gut Microbiome Committee, ILSI North America, August 20, 2020.
Publication: Abstracts and Presentations
/ Topics: Epidemiology , nutrition
Dronin-Fenton D, Dalvi T, Movva N , Pedersen I, Hansen H, Fryzek J, Mellemgaard A, Rasmussen T, et al. PD-L1 expression and survival in stage III unresectable non-small cell lung cancer patients in Denmark. Abstract #2865, European Society for Medical Oncology (ESMO), Virtual, August 2020.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Cancer
Su J, Bylsma LC , Jiang X , Morales Arias J, Jain N, Nordyke RJ. 2020. Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States. J Med Econ 23(8):902-907; doi: 10.1080/13696998.2020.1764006 . PMID: 32362156.
View Abstract
Publication: Manuscripts
/ Topics: Health Economics and Outcomes Research (HEOR)
Conrad F, Schober M, Nielsen D, Reichert H . 2020. Virtual interviewers, social identities, and survey measurement error. Chap 11 in: Olson K, Smyth JD, Dykema J, et al. (eds), Interviewer Effects from a Total Survey Error Perspective. CRC Press, Boca Raton, FL.
A Division of